Involvement of large tenascin-C splice variants in breast cancer progression - Wikidata - awgldk - TriplyDB

Involvement of large tenascin-C splice variants in breast cancer progression

Involvement of large tenascin-C splice variants in breast cancer progression

http://www.wikidata.org/entity/Q35791432

about

Splicing factor SRSF6 promotes hyperplasia of sensitized skin Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy Tenascin-C: Form versus function Tenascin-C and integrins in cancer Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage.Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.Innovative strategy for microRNA delivery in human mesenchymal stem cells via magnetic nanoparticles.Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels.Tenascins and the importance of adhesion modulation.Advances in tenascin-C biology.Tenascin C in metastasis: A view from the invasive front Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma A visual-quantitative analysis of fibroblastic stromagenesis in breast cancer progression.Similarities and dissimilarities of branching and septation during lung development.RNA sequencing of cancer reveals novel splicing alterations.Human matrix metalloproteinases: characteristics and pathologic role in altering mesangial homeostasis.Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients' survival SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration.Expression of tenascin-C and its isoforms in the breast.A matricellular protein and EGF-like repeat signalling in the social amoebozoan Dictyostelium discoideum.Role of tenascins in the ECM of gliomas.Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury.Role of tenascin-C in articular cartilage.Tenascin-C enhances crosstalk signaling of integrin αvβ3/PDGFR-β complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells.Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells.Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4 Comparative screening of glial cell types reveals extracellular matrix that inhibits retinal axon growth in a chondroitinase ABC-resistant fashion.A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4.Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion.Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial-mesenchymal transition-like change of breast cancer cells Distribution of myofibroblast and tenascin-C in cystic adventitial disease: comparison with ganglion.

P2860

Q24321623-DF900703-A278-4629-AE4D-BF346EC2F433 Q24672629-B26B9DC2-989E-4C50-8AD7-5E4D0FD271EC Q26864448-2F6A5E54-6B04-45F9-A0F9-D6266CBA7E23 Q26996081-E82D66C1-50B3-411F-AF6B-718FFEEB9B62 Q27023815-8AF460E6-84C7-464E-AFFD-86F9D0ACEA0F Q28082328-DD700110-C3F2-4391-87B2-D4CBA3A5F0F2 Q33962572-54A79F6D-54EB-4207-A4BD-06659E6A0860 Q34173505-092C9639-33AE-4124-8947-616CCC81D9AE Q34296481-C115DD80-EE27-4CC7-AD8B-1C1310D0F45F Q34490284-949482F4-68E4-4230-96D9-94CD0D0AEBB1 Q34736652-70C27387-A4D8-4356-A5CF-997FAEC59B83 Q34756114-DA68FDFF-1745-4E2D-BDFF-3874796E6514 Q34959853-722A7176-FF23-47C3-A5F4-A9B0DB0FF8D9 Q35006502-B3FAF6F3-3025-4054-A4F1-A8BB9FC03792 Q35214557-B8EA110A-679C-413E-A291-6053E3513942 Q35577928-3150ABE1-E6A2-46BF-84A8-00CC16EA7384 Q35885691-845D7F3C-1070-498C-ABBA-BF9DFB5F2542 Q36101819-B451B1BF-BDF3-4C96-81C1-93FDEF681AFF Q36167843-CD406A1F-EC0C-4188-9824-D7F6C5D0C902 Q36782437-412DFE29-EA3D-46B3-A48C-9BE3DEF8A37E Q37094734-FA135A63-E0CA-4385-B994-A0BDEE2D25F8 Q37190491-C0DC4751-E002-48F9-9AD0-6BCD31321BA5 Q37243488-B8966436-017B-4297-9C67-11DEDA941D04 Q37563571-C5F27972-7205-4BAF-BBA8-BE3852369B9E Q37600466-C411A6A5-B714-45D7-898F-DDC60D4E7EEE Q37631658-FF2644AB-4954-4681-96E2-8F423E1C3BC1 Q37785009-E617739B-5566-4751-9E57-76544DE32494 Q38025301-96C3142B-0C92-4497-9647-671FE01EAE5F Q38361238-D68A84DA-113E-4775-9B0F-CD1DB6E7C201 Q38594699-DECC8FE6-94C9-4AE4-A49B-D9B1BAE45715 Q39443859-79B07C21-996C-41A0-AFB9-E607234173D8 Q39500221-F370523A-D812-40DE-8249-F16FBF2C0F9D Q39540046-1B9B4647-704F-463E-B201-570A6AC5DA59 Q39761913-C41F062E-60B9-470A-AF0A-71BF2F922E2B Q39879870-22B079D4-4D12-4A68-A40A-E73457EC6DAB Q40075063-97EA9132-6E4A-40D5-8397-5642869EBFED Q40487608-016CA211-FD76-4072-82E7-F52DD1CB48B7 Q42501211-852D93F0-F740-4232-A799-41D7DD20C094 Q42579587-B68C3AB3-B7E9-4C92-A888-34EF6D47ACCE Q43941861-BA483631-465F-4ADC-8BA1-D0E23A0A184B

P2860

Involvement of large tenascin-C splice variants in breast cancer progression

http://www.wikidata.org/entity/Q35791432

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Involvement of large tenascin-C splice variants in breast cancer progression

@ast

Involvement of large tenascin-C splice variants in breast cancer progression

@en

type

label

Involvement of large tenascin-C splice variants in breast cancer progression

@ast

Involvement of large tenascin-C splice variants in breast cancer progression

@en

prefLabel

Involvement of large tenascin-C splice variants in breast cancer progression

@ast

Involvement of large tenascin-C splice variants in breast cancer progression

@en

P1433

Q35791432-6A567524-3F47-4A2A-AF43-C10D6ADF9190

P1476

Q35791432-C1B45A27-D78D-4C70-A47A-3620B3B7493F

P2093

Q35791432-008BB046-9986-4265-A91A-28E999897C05

Q35791432-0EF314AE-85B5-48EF-BFB7-7E8F4F688912

Q35791432-239AB89C-E7AE-41FF-9581-911C5354A113

Q35791432-8E0A35A7-DE14-47A0-B3CA-152C51E12287

Q35791432-BCDDA5F0-6E42-493D-A0D7-70AC3EFC1B6D

Q35791432-C360F054-CC6E-4E52-8711-0E8CFB499E4A

Q35791432-F1472E88-26D4-4E70-8779-73A7963873CD

Q35791432-F5F469CE-1B45-4BD9-AFC7-A31CA5F99195

Q35791432-F7894E0D-A8CB-4FFD-AAAD-3EF854029A44

Q35791432-F83214BD-9C2F-4213-A724-7918DBCC3D79

P2860

Q35791432-012B10AB-16BB-4A99-A07B-C74FE7950A95

Q35791432-0867AE0D-FFDE-4B06-8386-08460E49927D

Q35791432-0A116B50-F469-4556-B62C-299CAAF88DE4

Q35791432-0F4F7590-51D0-4B78-86EB-2FB68253097B

Q35791432-142773A0-5480-48EC-A3D8-2268F5BE9E51

Q35791432-1644B012-2A5A-47A4-AECC-71B364C7C94E

Q35791432-22D3A7A3-B86D-4324-8178-77560176E191

Q35791432-25B12C91-EF9A-4D44-BFE6-5CE2BCACB8F3

Q35791432-339A64D0-212B-46E3-8D1E-F25A8DE9ADC6

Q35791432-34CB01A3-04A7-4F9C-9EF0-4DF842E77AE6

P304

Q35791432-67821AE0-8E25-42F4-9BB8-A4998D35C103

P31

Q35791432-B4C170E9-6EDC-4386-850F-8314C29B1E27

P356

Q35791432-FD92D612-5B32-4BF6-ACBE-E4F6A30C9CCA

P407

Q35791432-29491293-3168-40FC-8FE5-7DD47A9F8EE1

P433

Q35791432-8FECECD4-C0C3-41CC-ADD7-0C7305CDA9DE

P478

Q35791432-10334613-5758-441C-B0D3-A91F9D3ABB82

P577

Q35791432-235DFEDA-93EB-4A23-AAE3-A1ED0BBA9896

P698

Q35791432-FB24C7BD-A95B-4F51-AF65-553AF1189F3C

P932

Q35791432-55E0ADA3-C100-440A-884F-B924CCCCFEA3

P356

S0002-9440(10)64320-9

P1433

The American Journal of Pathology

P1476

Involvement of large tenascin-C splice variants in breast cancer progression

@en

P2093

Hiroyasu Inada

http://www.w3.org/2001/XMLSchema#string

Ilunga Kalembeyi

http://www.w3.org/2001/XMLSchema#string

Koji Katsuta

http://www.w3.org/2001/XMLSchema#string

Kyoko Imanaka-Yoshida

http://www.w3.org/2001/XMLSchema#string

Mirei Sakakibara

http://www.w3.org/2001/XMLSchema#string

Ray Okada

http://www.w3.org/2001/XMLSchema#string

Takatsugu Tsunoda

http://www.w3.org/2001/XMLSchema#string

Teruyo Sakakura

http://www.w3.org/2001/XMLSchema#string

Toshimichi Yoshida

http://www.w3.org/2001/XMLSchema#string

Yuichi Majima

http://www.w3.org/2001/XMLSchema#string

P2860

Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies

Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C

The complete cDNA sequence of human hexabrachion (Tenascin). A multidomain protein containing unique epidermal growth factor repeats

The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling

The clinical significance of tenascin-C splice variant expression in chondrosarcoma

Tenascin-C is a useful marker for disease activity in myocarditis

The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?

The microenvironment of the tumour-host interface

Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody

Murine tenascin: cDNA cloning, structure and temporal expression of isoforms.

P304

1857-1867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)64320-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12759243

http://www.w3.org/2001/XMLSchema#string

P932

1868127

http://www.w3.org/2001/XMLSchema#string